Neuland Laboratories Ltd Half Yearly Results

Gross Sales

750.45

777.84

780.74

676.32

514.88

Excise Duty

0

0

0

0

0

Net Sales

750.45

777.84

780.74

676.32

514.88

Other Operating Income

0

0

0

0

0

Other Income

29.77

7.46

5.09

9

0.75

Total Income

780.21

785.3

785.83

685.32

515.63

Total Expenditure

564.86

549.66

546.34

502.38

416.97

PBIDT

215.35

235.64

239.49

182.94

98.65

Interest

3.73

7.35

6.65

7.03

6.03

PBDT

211.62

228.29

232.85

175.9

92.62

Depreciation

32.35

31.61

28.09

26.81

25.97

Minority Interest Before NP

0

0

0

0

0

Tax

42.79

47.28

52.39

32.01

18.43

Deferred Tax

5.76

0.45

1.24

2

-0.21

Reported Profit After Tax

130.72

148.95

151.13

115.09

48.43

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

130.72

148.95

151.13

115.09

48.43

Extra-ordinary Items

15.04

0

0

0

0

Adjusted Profit After Extra-ordinary item

115.68

148.95

151.13

115.09

48.43

EPS (Unit Curr.)

101.88

115.46

117.79

89.22

37.74

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

12.9

12.9

12.9

12.9

12.9

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.69

30.29

30.67

27.04

19.15

PBDTM(%)

-

-

-

-

-

PATM(%)

17.41

19.14

19.35

17.01

9.4